Professor & UroOncologist @UWurology; SUO Fellowship Director; Assoc Editor @EUPlatinum; Trialist committed to improving survivorship in GU cancers
Seattle, WA
Joined May 2013
- Tweets2.3K
- Following852
- Followers4.1K
- Likes9.9K
Sarah P. Psutka MD MS retweeted
Different PRO measures across oncology trials can make it difficult to compare how patients feel & function
In this @PsyOnc editorial with @montypal @PauloBergerot , we discuss how score harmonization can bridge evidence while respecting meaningful differences between measures
🔗 onlinelibrary.wiley.com/doi/…
Sarah P. Psutka MD MS retweeted
Just released in @NatRevUrol : Integrating clinically actionable biomarkers into bladder cancer care : recommendations from the International Bladder Cancer Group @IBCG_BladderCA
During our deliberations, one theme was clear: biomarkers don't improve care simply because they're "novel or new" They improve care when they're validated, reproducible, and actually change clinical decisions 🧵
@pjhensley11 @jteoh_hk @UrogerliMD @shilpaonc @LauraBukavinaMD @mouwlab @AndreaNecchi @niyatilobo @Agarwal_CaB @LiangChengMD @karima_oualla @drtanws @MaxKates @BrigidaMaiorano @h_alahmadie @TomFlaigMD @AmirHorowitz @WesKassouf @djmcconkey @JanetKukreja @LAUrology_NL @carme_mir1 @UroMoschini @BogdanaSchmidt @VigneshPackiam
Sarah P. Psutka MD MS retweeted
🎉 Registration for our 2026 International Kidney Cancer Symposium (IKCS): North America is open! #IKCSNA26
Early registration rates available now. We're excited to welcome you to Dallas!
Reserve your spot to join us 👉 web.cvent.com/event/885b2adb…
Sarah P. Psutka MD MS retweeted
Quality-of-life outcomes remain substantially underreported in GU cancer trials, with evidence suggesting outcome-dependent reporting bias @JCOOA_ASCO @KalantriShreyas
ascopubs.org/doi/pdf/10.1200…
Sarah P. Psutka MD MS retweeted
BOND-003 Cohort C data in @TheLancetOncol
A 75% CR rate at any time, with a median follow-up of 25.8 months and no grade 3/4 treatment-related adverse events, represents an important contribution to the evolving treatment landscape for BCG-unresponsive NMIBC.
Advances like this don’t happen overnight. They are built on patients willing to participate, investigators who believe early, committed clinical teams, and industry partners who stay the course.
Science is a team sport. Congratulations to everyone involved.
sciencedirect.com/science/ar…
@MarkTysonMD @UrogerliMD @garysteinbergmd @tbivala1 @JamesBurke34034 @cgoncology @KuanArthur @IBCG_BladderCA
Sarah P. Psutka MD MS retweeted
New in @JAMANetworkOpen: @SWOG S1600, a multicenter phase 3 RCT, found no reduction in 30- or 90-day complications w/ specialized immunonutrition vs standard nutrition after cystectomy. Exploratory DFS/OS favored immunonutrition. #BladderCancer
@JhamiltonReeves @DrJoeUnger @JMHolzbeierlein @FoxChaseCancer @BCM_Urology @JanetKukreja @eugenekanglee @URMCUrology @DrDawnHershman @fischmd @lynnhenrymd jamanetwork.com/journals/jam…
Sarah P. Psutka MD MS retweeted
⭐Abstract Submissions Are OPEN!⭐
Submit your abstracts now for the KCA's upcoming 2026 IKCS: North America meeting 🔗 bit.ly/3R4biXG
Sarah P. Psutka MD MS retweeted
Let’s not forget the BRIGHT trial (@SWOG S2427) -Phase II study evaluating a bladder-preservation strategy for patients with #MIBC who achieve a meaningful response to neoadjuvant therapy—using pembrolizumab + radiation instead of immediate radical cystectomy in carefully selected patients. @l_ballas @AbhiTrip87 @MarkTysonMD @mouwlab @JoshMeeks @djmcconkey @KyleRoseMD @DrKarineTawagi @SeanSachdevMD @kritimittalmd
If a patient in front of you refuses RC after EVP, the honest answer is enrollment in a prospective surveillance protocol with predefined imaging and biopsy triggers for salvage therapy. (EV-209; NCT07475806)
NOT quiet endorsement of surveillance as standard of care.
@scserendipity1 @tompowles1 @AndreaNecchi @shilpaonc @siadaneshmand @UrogerliMD @bbmdmsk @joanfundi @IBCG_BladderCA @drenriquegrande @JoshMeeks
Sarah P. Psutka MD MS retweeted
Today is the 2027 Society of Urologic Oncology (SUO) Fellowship Match Day, and we are excited to welcome our incoming fellow, Margaret Meagher, MD, from the University of California San Diego!
Please join us in congratulating Dr. Meagher on matching with our program. We look forward to welcoming her in July of 2027!
Sarah P. Psutka MD MS retweeted
Please open and enroll to GAIN. @eugene_pietzak gem-bcg. Bcg exposed. Great trial. We have open and enrolling @NM_Urology
Sarah P. Psutka MD MS retweeted
Kicking off the @AmerUrological #YoungUrologists Forum with a well-deserved recognition of @AmyLuckenbaugh who is proof that women really can do it ALL! A gifted surgeon, healer, leader, mom, friend and the @SES_AUA Young Urologist of the Year 😍🎉
Sarah P. Psutka MD MS retweeted
🏋️ Yay for exercise- Level 1 evidence that it improves survival in cancer! If exercise were a drug it would be FDA approved! Exercise should be considered a vital sign to discuss with all patients and is feasible even in metastatic disease! @charlesryanmd #apccc26
So incredibly proud of @alexzhuDO presenting his #Vogelzang scholar lecture at #SWOG2026 - Alex is the ultimate clinical trialist, he takes real clinical problems and develops pragmatic trials with practice-changing impact.
So excited for his future as he launches from @uwurology to the next stage of his career @cityofhope @montypal @UroOnc @DanLinMD @PGrivasMDPhD
Sarah P. Psutka MD MS retweeted
Meet Jaya Goud: Researcher, Student, and Trailblazer!
At just 16, Jaya was selected as an oral abstract presenter at #IKCSEU26, where she shared her research on global disparities in kidney cancer clinical trials.
The future is bright with researchers like Jaya. 🧡 @cityofhope
Sarah P. Psutka MD MS retweeted
@spsutkaMD from @UWMedicine is already looking ahead to #IKCSNA26!!!
Mark your calendars for Nov 19-21 in Dallas, Texas. The program committee is working hard to bring you another year of exceptional breakthroughs and progress in kidney cancer care! 🤝
Sarah P. Psutka MD MS retweeted
🎉CONGRATULATIONS to Dr. Samra Turajlic @CRUK_MI recipient of the KCA's Pieter de Mulder Award for oncologists who have made significant contributions to #kidneycancer treatment. The award will be presented at #IKCSEU26 don't miss her lecture!
Register 🔗 web.cvent.com/event/9d248aca…
Sarah P. Psutka MD MS retweeted
Proud to have 🤩🤩 local hero @kategessner_uro sharing this important work at #EAU26
Wonderful overview of the CISTO study regarding quality of life following bladder preservation or cystectomy by @kategessner_uro at EAU2026 in London. @UNCurology @UNCUroOnc @UNC_Lineberger
Sarah P. Psutka MD MS retweeted
What a whirlwind #EAU26 with @EUplatinum family from meetings , presentations, debates , planning , traveling 🚊 celebrating together another successful year @GGiannarini @Yasminabugh @declangmurphy @RenuEapen @ChapinMD @JimCatto @Albert0Briganti @spsutkaMD
